BREAST CANCER (TRIPLE NEGATIVE BREAST CANCER (TNBC))
Clinical trials for BREAST CANCER (TRIPLE NEGATIVE BREAST CANCER (TNBC)) explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER (TRIPLE NEGATIVE BREAST CANCER (TNBC)) trials appear
Sign up with your email to follow new studies for BREAST CANCER (TRIPLE NEGATIVE BREAST CANCER (TNBC)), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets Hard-to-Treat breast cancer
Disease control Not yet recruitingThis Phase 2 trial tests a new drug called HLX43, which is designed to seek out and destroy cancer cells in people with advanced triple-negative breast cancer (TNBC). The study will test HLX43 alone or combined with other immune-boosting drugs. About 180 adults with TNBC that has…
Matched conditions: BREAST CANCER (TRIPLE NEGATIVE BREAST CANCER (TNBC))
Phase: PHASE2 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can a chemo combo without anthracyclines still beat breast cancer?
Knowledge-focused Not yet recruitingThis study looks at how well a chemotherapy and immunotherapy combination works for early triple-negative breast cancer when the usual anthracycline drugs are left out. The researchers are focusing on patients who cannot take anthracyclines due to previous treatment, older age, o…
Matched conditions: BREAST CANCER (TRIPLE NEGATIVE BREAST CANCER (TNBC))
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC